The MRC funds medical research and training from fundamental lab-based science to clinical trials, and in all disease areas. We internationally in partnership with public and charity funders, with industry, regulators, policy makers and the public to deliver its mission. In deciding which research to support, the MRC places priority on discovery science that is likely to make a difference to clinical practice and improve human health.
The Investing for Impact report highlights the benefits derived from MRC-funded research and reflects the focus of the MRC Delivery Plan (PDF, 523KB) and the MRC's strategic objectives as outlined in Research Changes Lives 2014-2019 (PDF, 2.15MB). We have selected case studies of reported research impact realised during 2015/2016 and that highlight MRC-led strategic initiatives. For quantitative analysis, we have analysed the MRC’s investments and reported outputs over the last five years placed in the context of 10 years of MRC funding.
The report focuses on priorities highlighted by the MRC which aim to address major health and societal challenges in the UK and globally. Furthermore, other areas of research, training, and targeted approaches to funding innovative and effective research remain important to the MRC. The MRC funds cutting edge research where it occurs; either regionally-focused or across the entire UK.